Authors: Debruyne, FMJ Witjes, WPJ

Citation: Fmj. Debruyne et Wpj. Witjes, Neoadjuvant hormonal therapy prior to radical prostatectomy: The European experience, MOL UROL, 4(3), 2000, pp. 251-256

Authors: Schulman, CC Debruyne, FMJ Forster, G Selvaggi, FP Zlotta, AR Witjes, WPJ

Citation: Cc. Schulman et al., 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer, EUR UROL, 38(6), 2000, pp. 706-713

Authors: Witjes, WPJ Konig, M Boeminghaus, FP Hall, RR Schulman, CC Zurlo, M Fittipaldo, A Riggi, M Debruyne, FMJ

Citation: Wpj. Witjes et al., Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder, EUR UROL, 36(6), 1999, pp. 576-581

Authors: Debruyne, FMJ Witjes, WPJ

Citation: Fmj. Debruyne et Wpj. Witjes, Neoadjuvant hormone treatment in localized prostate cancer: a critical appraisal, TEXTBOOK OF PROSTATE CANCER, 1999, pp. 249-259

Authors: Witjes, WPJ Schulman, CC Debruyne, FMJ

Citation: Wpj. Witjes et al., Results of a European randomized study comparing radical prostatectomy andradical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3N0M0 prostatic carcinoma, MOL UROL, 2(3), 1998, pp. 181-185